➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Dow
Express Scripts
Baxter
McKinsey

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

PREDNICARBATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Prednicarbate patents expire, and what generic alternatives are available?

Prednicarbate is a drug marketed by Fougera Pharms and is included in two NDAs.

The generic ingredient in PREDNICARBATE is prednicarbate. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the prednicarbate profile page.

US ANDA Litigation and Generic Entry Outlook for Prednicarbate

A generic version of PREDNICARBATE was approved as prednicarbate by FOUGERA PHARMS on March 9th, 2007.

  Start Trial

Drug patent expirations by year for PREDNICARBATE
Drug Prices for PREDNICARBATE

See drug prices for PREDNICARBATE

Recent Clinical Trials for PREDNICARBATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Handok Pharmaceuticals Co., Ltd.Phase 4

See all PREDNICARBATE clinical trials

Pharmacology for PREDNICARBATE

US Patents and Regulatory Information for PREDNICARBATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PREDNICARBATE prednicarbate CREAM;TOPICAL 077287-001 Sep 19, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Fougera Pharms PREDNICARBATE prednicarbate OINTMENT;TOPICAL 077236-001 Mar 9, 2007 RX No Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Moodys
Mallinckrodt
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.